Venture capital fund Healthquad completed its final close of Rs. 750 million

Country’s healthcare-focused venture capital fund, Healthquad has completed its final close with a total commitment of Rs. 750 million for investing in thematic and disruptive healthcare business models in India.

Talking about the funding Managing Partner Amit Varma said, ” Healthcare sector has seen emergence of over 500 startups in the last two years and venture capital firms have infused around 25 billion rupees. We are looking to deploy around four billion rupees, along with co-investors and partner funds in healthcare models that are driven by new age disruptive technology and are changing the way healthcare is delivered and accessed in India.”

Venture capital fund Healthquad completed its final of Rs. 750 million

HealthQuad venture fund is the first early stage investment vehicle by the leading healthcare private equity investors Amit Varma, Abrar Mir and Charles Antione Janssen. It was launched with an initial corpus of $10 Mn (INR 65 Cr) in June 2016.

The venture capital firm garners strong investor interest from accomplished healthcare professionals and investors and leading institutions from Europe.

“Our deployments in healthcare across sub-sectors and geographies provide extensive synergies to help companies scale-up rapidly and that forms the basis of our compelling proposition to healthcare entrepreneurs in India,” Fund’s co-sponsor Abrar Mir added.

The Fund targets to invest around four billion rupees in healthcare companies that have the potential to disrupt the healthcare landscape by improving the productivity, affordability and accessibility of healthcare through differentiated and innovative solutions.

“Our first four Healthquad investments have confirmed that business model innovations and health tech innovations will open access to quality healthcare for hundreds of millions of neglected Indians. Our final close will allow us to fund more, fast growing, profitable and highly impactful companies. We look forward to supporting great entrepreneurs for the benefit of patients as well as our LPs,” Lastly, Charles Antione Janssen, Fund’s third co-sponsor said.

LEAVE A REPLY

Please enter your comment!
Please enter your name here